{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-112340","form_type":"8-K","ticker":"REGN","cik":"0000872589","company_name":"REGENERON PHARMACEUTICALS, INC.","filed_at":"2026-09-30T20:14:08+00:00","discovered_at":"2026-09-30T20:15:00.479764+00:00","generated_at":"2026-10-12T14:05:13.735812+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Regeneron grants Schleifer, Yancopoulos 10-year PSU awards capped at 2.7M/2.9M shares","bullets":["2026 PSUs granted Sept 24, 2026 replace annual equity awards for CEO Leonard Schleifer and CSO George Yancopoulos until 2036; no other equity awards permitted before 2036.","Earnout: 10,000 PSUs per new product BLA/NDA filing, 15,000 per FDA approval, 12,500 per qualifying sBLA/sNDA; 1,800,000 PSUs if New Product Annual Revenues hit $30B.","Below $10B of new product revenue, no revenue PSUs are earned and activity PSUs cap at 100,000 (CEO)/300,000 (CSO); absolute caps are 2,700,000 and 2,900,000 PSUs.","Shares cannot be sold until February 2036; a relative TSR modifier vs the NASDAQ Biotechnology Index adjusts earned PSUs by +/-20%; 20% holdback applies before period end.","Regeneron formed a majority-owned New Subsidiary for a potential non-core opportunity; Schleifer and Yancopoulos each received a partly vesting stake; it has nominal value and no operations yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-112340","json":"https://secwatch.observer/filing/0001104659-26-112340.json","markdown":"https://secwatch.observer/filing/0001104659-26-112340.md","text":"https://secwatch.observer/filing/0001104659-26-112340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/0001104659-26-112340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/tm2626090d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:05:13.735812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}